Aegis Capital Starts ZELTIQ Aesthetics (ZLTQ) at Buy; Likes Position in non-Invasive Fat Reduction
Tweet Send to a Friend
Aegis Capital starts coverage on ZELTIQ Aesthetics (Nasdaq: ZLTQ) at Buy with a price target of $51.Analyst Difei Yang commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
